Works matching DE "IMMUNE checkpoint proteins"
Results: 4883
SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02093-2
- By:
- Publication type:
- Article
Pan-cancer analysis predicts MBOAT2 as a potential new ferroptosis related gene immune checkpoint.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02078-1
- By:
- Publication type:
- Article
Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy.
- Published in:
- Angewandte Chemie, 2025, v. 137, n. 5, p. 1, doi. 10.1002/ange.202417027
- By:
- Publication type:
- Article
Unveiling ac4C modification pattern: a prospective target for improving the response to immunotherapeutic strategies in melanoma.
- Published in:
- Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06297-6
- By:
- Publication type:
- Article
Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer.
- Published in:
- Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03154-y
- By:
- Publication type:
- Article
SPP1 as a Prognostic and Immunotherapeutic Biomarker in Gliomas and Other Cancer Types: A Pan-Cancer Study.
- Published in:
- Journal of Inflammation Research, 2025, v. 18, p. 2247, doi. 10.2147/JIR.S505237
- By:
- Publication type:
- Article
Single-Cell RNA Sequencing Reveals Peripheral Immune Cell Senescence and Inflammatory Phenotypes in Patients with Premature Ovarian Failure.
- Published in:
- Journal of Inflammation Research, 2025, v. 18, p. 2699, doi. 10.2147/JIR.S496130
- By:
- Publication type:
- Article
Weighted Gene Coexpression Network Analysis Identifies Neutrophil-Related Molecular Subtypes and Their Clinical Significance in Gastric Cancer.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 397, doi. 10.2147/CMAR.S500215
- By:
- Publication type:
- Article
A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03337-3
- By:
- Publication type:
- Article
Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03318-6
- By:
- Publication type:
- Article
Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy.
- Published in:
- Journal of Leukocyte Biology, 2025, v. 117, n. 2, p. 1, doi. 10.1093/jleuko/qiae158
- By:
- Publication type:
- Article
Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case report.
- Published in:
- European Heart Journal Case Reports, 2025, v. 9, n. 2, p. 1, doi. 10.1093/ehjcr/ytaf019
- By:
- Publication type:
- Article
Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming.
- Published in:
- Science Translational Medicine, 2025, v. 17, n. 788, p. 1, doi. 10.1126/scitranslmed.ado0020
- By:
- Publication type:
- Article
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1554372
- By:
- Publication type:
- Article
Polyamine metabolism and anti-tumor immunity.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1529337
- By:
- Publication type:
- Article
Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis.
- Published in:
- Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02368-1
- By:
- Publication type:
- Article
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1538658
- By:
- Publication type:
- Article
Aptamer based immunotherapy: a potential solid tumor therapeutic.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1536569
- By:
- Publication type:
- Article
Vascular E-selectin Expression Recognized by the U12-12 Monoclonal Antibody as a Predictive Marker for Steroid Resistance in Immune Checkpoint Inhibitor-related Colitis.
- Published in:
- Journal of Histochemistry & Cytochemistry, 2025, v. 73, n. 1/2, p. 81, doi. 10.1369/00221554251320703
- By:
- Publication type:
- Article
A bibliometric and visualization analysis of the role of traditional Chinese medicine in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1499026
- By:
- Publication type:
- Article
Effects of c-Kit Receptor, AKT, and NF-κB Inhibitors on Immune Evasion in Multiple Myeloma Cells.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2025, v. 24, n. 1, p. 89, doi. 10.18502/ijaai.v24i1.18024
- By:
- Publication type:
- Article
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy.
- Published in:
- Journal of Personalized Medicine, 2025, v. 15, n. 2, p. 50, doi. 10.3390/jpm15020050
- By:
- Publication type:
- Article
Prognostic Biomarkers in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Focus on B7-H3.
- Published in:
- Brain Sciences (2076-3425), 2025, v. 15, n. 2, p. 212, doi. 10.3390/brainsci15020212
- By:
- Publication type:
- Article
Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel Immune Checkpoint Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 293, doi. 10.3390/biom15020293
- By:
- Publication type:
- Article
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 240, doi. 10.3390/biom15020240
- By:
- Publication type:
- Article
Targeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer Therapies.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 237, doi. 10.3390/biom15020237
- By:
- Publication type:
- Article
UVC-Induced Oxidative Stress and DNA Damage Repair Status in Head and Neck Squamous Cell Carcinoma Patients with Different Responses to Nivolumab Therapy.
- Published in:
- Biology (2079-7737), 2025, v. 14, n. 2, p. 195, doi. 10.3390/biology14020195
- By:
- Publication type:
- Article
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 257, doi. 10.3390/pharmaceutics17020257
- By:
- Publication type:
- Article
Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 139, doi. 10.3390/pharmaceutics17020139
- By:
- Publication type:
- Article
Retinol-Binding Protein 4 as a Biomarker in Cancer: Insights from a Pan-Cancer Analysis of Expression, Immune Infiltration, and Methylation.
- Published in:
- Genes, 2025, v. 16, n. 2, p. 150, doi. 10.3390/genes16020150
- By:
- Publication type:
- Article
Exploring the application of metal-based photothermal agents in photothermal therapy combined with immune checkpoint therapy.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1553158
- By:
- Publication type:
- Article
Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 500, doi. 10.3390/biomedicines13020500
- By:
- Publication type:
- Article
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 470, doi. 10.3390/biomedicines13020470
- By:
- Publication type:
- Article
Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 276, doi. 10.3390/biomedicines13020276
- By:
- Publication type:
- Article
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1200, doi. 10.3390/jcm14041200
- By:
- Publication type:
- Article
Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1455347
- By:
- Publication type:
- Article
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1563383
- By:
- Publication type:
- Article
Oligometastatic NSCLC: Current Perspectives and Future Challenges.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 75, doi. 10.3390/curroncol32020075
- By:
- Publication type:
- Article
Incidence of and Risk Factors for Anti-PD-1/PD-L1- Associated Diarrhea and Colitis: A Retrospective Cohort Study of the Chinese Population.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 2, p. 353, doi. 10.3390/medicina61020353
- By:
- Publication type:
- Article
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.
- Published in:
- Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06207-w
- By:
- Publication type:
- Article
Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1574, doi. 10.3390/ijms26041574
- By:
- Publication type:
- Article
A Novel Prognostic Signature of Mitophagy-Related E3 Ubiquitin Ligases in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1551, doi. 10.3390/ijms26041551
- By:
- Publication type:
- Article
Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes.
- Published in:
- NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00842-8
- By:
- Publication type:
- Article
Gene Expression Signatures of Porcine Bone Marrow-Derived Antigen-Presenting Cells Infected with Classical Swine Fever Virus.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 160, doi. 10.3390/v17020160
- By:
- Publication type:
- Article
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 4, p. 709, doi. 10.1111/vco.12934
- By:
- Publication type:
- Article
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 255, doi. 10.1111/vco.12884
- By:
- Publication type:
- Article
VCS abstract.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, p. 3, doi. 10.1111/vco.12867
- Publication type:
- Article
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 427, doi. 10.1111/vco.12788
- By:
- Publication type:
- Article
Development of Platinum Complexes for Tumor Chemoimmunotherapy.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 10, p. 1, doi. 10.1002/chem.202302948
- By:
- Publication type:
- Article
Monitoring ROS Responsive Fe<sub>3</sub>O<sub>4</sub>‐based Nanoparticle Mediated Ferroptosis and Immunotherapy via <sup>129</sup>Xe MRI.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 22, p. 1, doi. 10.1002/ange.202403771
- By:
- Publication type:
- Article